Meningococcal Vaccine
The Meningococcal vaccine is recommended by the Indian Academy of Pediatrics (IAP) to protect against meningococcal disease, a serious bacterial illness caused by the bacterium Neisseria meningitidis. Meningococcal disease can lead to meningitis (infection of the lining of the brain and spinal cord) and meningococcal septicemia (bloodstream infection). Here’s an overview of the IAP guidelines for the Meningococcal vaccine:
Understanding Meningococcal Disease
-
Disease Overview: Meningococcal disease can cause severe brain and spinal cord infections or a life-threatening blood infection.
-
Risk Factors: Close contact settings, travel to endemic areas, certain medical conditions increase the risk.
Meningococcal Vaccine
Purpose: To protect against Neisseria meningitidis, which has multiple serogroups including A, C, W, Y, and B.
Types of Vaccines: Meningococcal conjugate vaccines (MCV4) targeting serogroups A, C, W, Y and MenB vaccines targeting serogroup B.
Types of Vaccines: Meningococcal conjugate vaccines (MCV4) targeting serogroups A, C, W, Y and MenB vaccines targeting serogroup B.
IAP Recommended Schedule for Meningococcal Vaccination
Target Group: Recommended for children and adolescents in certain high-risk groups.
Vaccination Schedule:
– MCV4: First dose at 9-12 months of age with a booster dose at 2 years of age. For unvaccinated older children and adolescents, a single dose is recommended.
– MenB Vaccine: Administered in adolescents and young adults, especially in outbreak situations or for those at increased risk.
Travelers and High-Risk Groups: Vaccination recommended for travelers to endemic regions and individuals with certain medical conditions like asplenia or complement component deficiencies.
Vaccination Schedule:
– MCV4: First dose at 9-12 months of age with a booster dose at 2 years of age. For unvaccinated older children and adolescents, a single dose is recommended.
– MenB Vaccine: Administered in adolescents and young adults, especially in outbreak situations or for those at increased risk.
Travelers and High-Risk Groups: Vaccination recommended for travelers to endemic regions and individuals with certain medical conditions like asplenia or complement component deficiencies.
Vaccine Administration
Method: The vaccine is usually administered as an intramuscular injection.
Safety and Side Effects
Common Side Effects: Pain at the injection site, mild fever, fatigue.
Serious Side Effects: Very rare, but can include allergic reactions.
Serious Side Effects: Very rare, but can include allergic reactions.
Who Should Receive the Vaccine
High-Risk Groups: Including those with certain medical conditions, or those traveling to endemic areas.
General Population: Not routinely recommended for all children, but may be advised for those in high-risk groups.
General Population: Not routinely recommended for all children, but may be advised for those in high-risk groups.
Who Should Not Receive the Vaccine
– Individuals with a known severe allergic reaction to any component of the Meningococcal vaccine.
– Those with a moderate or severe acute illness should wait until recovery.
– Those with a moderate or severe acute illness should wait until recovery.
Importance in Public Health
The Meningococcal vaccine is crucial for preventing meningococcal disease in high-risk populations.
Consultation with Healthcare Professionals
Consultation with a healthcare provider is recommended for personalized advice and to determine if the vaccine is appropriate based on individual risk factors.
Disclaimer
-
This information is for educational purposes only and may not reflect the most current data available. Always consult a pediatrician or healthcare professional for medical advice and before making any vaccination decisions. We strive to keep this information updated, but it may not be updated in real time
-
Consultation with healthcare professionals is essential for personalized advice and to address specific health concerns.
CALL +91 96060 77401 to schedule the appointment today
Contact us
Call us
+91 96060 77401
Visit us at
Aloha Kids Clinic
No 531, 2nd Floor,
Nammalaya Building
Doddakallasandra,
Bangalore – 560062
Send us an email
admin@alohakidsclinic.com
About us
Subscribe
Sign up for the Aloha newsletter to receive all the news offers and discounts from the Aloha Kids clinic.
Contact us
Call us
+91 96060 77401
Visit us at
Aloha Kids Clinic
No 531, 2nd Floor,
Nammalaya Building,
Doddakallasandra,
Bangalore – 560062
Send us an email
admin@alohakidsclinic.com
About us
Subscribe
Sign up for the Aloha newsletter to receive all the news offers and discounts from Aloha Kids clinic.
Copyright by Aloha Kids Clinic,2023. All rights reserved.
Copyright by Aloha kids clinic,2023 All rights reserved.